As of April 2024 Tonix Pharmaceuticals has a market cap of $15.28 Million. This makes Tonix Pharmaceuticals the world's 8033th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $15.28 M | -35.28% |
2023 | $23.62 M | 5.32% |
2022 | $22.42 M | -87.37% |
2021 | $0.17 B | 37.22% |
2020 | $0.12 B | 1195.98% |
2019 | $9.98 M | 39.52% |
2018 | $7.15 M | -73.52% |
2017 | $27.01 M | 46.66% |
2016 | $18.41 M | -87.25% |
2015 | $0.14 B | 128.89% |
2014 | $63.1 M | 5.11% |
2013 | $60.03 M | 152.79% |
2012 | $23.74 M |
On Apr 19th, 2024 the market cap of Tonix Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Aerie Pharmaceuticals AERI | $0.75 B | 4,829.78% | ๐บ๐ธ USA |
Eagle Pharmaceuticals
EGRX | $59.73 M | 290.77% | ๐บ๐ธ USA |